|
| Tuesday, December 9, 2025 |
|
|
Majority of Australian Parents (65%) and U.S. Parents 58% Support Social Media Ban for Under 16s, but Kids Say It Risks Cutting Them Off from Key Connections |
| The Family Online Safety Institute (FOSI) released new research today examining how parents and children in the United States and Australia view social media bans for anyone under 16. more info >> |
|
|
Cyara Appoints Sushil Kumar as CEO to Extend Enterprise AI Customer Experience (CX) Leadership |
| Cyara, the global leader in AI-powered customer experience (CX) assurance, today announced the appointment of Sushil Kumar as its new Chief Executive Officer. more info >> |
|
| Thursday, December 4, 2025 |
|
|
The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food |
| You have seen the videos and read the blogs. Now you are finally planning your own food pilgrimage to Japan. We are talking about that perfect, silky bowl of ramen, sushi that melts in your mouth, and hot takoyaki straight from the griddle. more info >> |
|
| Wednesday, December 3, 2025 |
|
|
OMP's AI-driven Unison Planning(TM) Platform Enhances Supply Chain Agility for McCormick & Co. |
| OMP is helping McCormick & Co., the global leader in flavor, with an AI-driven and autonomous operational planning initiative. This partnership enables McCormick to manage both assembly-to-order (ATO) and make-to-stock (MTS) production within the Unison Planning platform. more info >> |
|
| Tuesday, December 2, 2025 |
|
|
OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams |
| As scammers adopt increasingly sophisticated methods powered by artificial intelligence, global coordination and responsible innovation have become essential to protecting consumers. more info >> |
|
|
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases |
| GEN Pharmaceuticals (GENIL.IS), Turkiye's leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class, novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. more info >> |
|
| Thursday, November 20, 2025 |
|
|
OMP Miami Conference 2025: Transforming Supply Chain Vision into REAL Impact with Human-AI Synergy |
| OMP, a global leader in supply chain planning solutions, brought together global supply chain executives, technology innovators, and strategic partners at the OMP REAL Conference 2025 in Miami. more info >> |
|
|
U.S. Polo Assn. Receives Multiple Global Honors Recognizing Excellence in Brand, Content, and Digital Growth |
| USPA Global today announced that U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has been recognized for several prestigious international awards recognizing the brand's excellence across sports, fashion, retail, media, and digital categories. more info >> |
|
| Tuesday, November 18, 2025 |
|
|
Icarus' Future: A Miami-Born Campaign Telling COP30 Leaders Our Children's Future is at Stake - Just Won Seven LUUM Awards |
| Our Present, Icarus' Future reframes the delay on climate action by centering parents, children, and human stories - using a visceral installation, a global petition, and an art contest to translate feeling into civic pressure ahead of COP30. Because the policy choices made today will determine the life chances of children born this year. more info >> |
|
| Monday, November 17, 2025 |
|
|
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 2026 |
| Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. more info >> |
|
|
|
|
